Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma

Παρόμοια τεκμήρια

• Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
  ανά: Croucher, P, κ.ά.
  Έκδοση: (2001)
• Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
  ανά: Croucher, P, κ.ά.
  Έκδοση: (2000)
• Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
  ανά: Croucher, P, κ.ά.
  Έκδοση: (2003)
• Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
  ανά: Croucher, P, κ.ά.
  Έκδοση: (2001)
• Osteoprotegerin and the development of myeloma bone disease
  ανά: Croucher, P, κ.ά.
  Έκδοση: (2004)